These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34026950)

  • 1. Lipocalin 2 serum levels correlate with age and bone turnover biomarkers in healthy subjects but not in postmenopausal osteoporotic women.
    Maurizi A; Ponzetti M; Gautvik KM; Reppe S; Teti A; Rucci N
    Bone Rep; 2021 Jun; 14():101059. PubMed ID: 34026950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship among serum lipocalin 2, bone turnover markers, and bone mineral density in outpatient women.
    Liu DM; Zhao HY; Zhao L; Zhang MJ; Liu TT; Tao B; Sun LH; Liu JM
    Endocrine; 2018 Feb; 59(2):304-310. PubMed ID: 29294226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density.
    Rossini M; Viapiana O; Adami S; Fracassi E; Idolazzi L; Dartizio C; Povino MR; Orsolini G; Gatti D
    Clin Exp Rheumatol; 2015; 33(1):77-83. PubMed ID: 25438096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis.
    Orsolini G; Adami G; Rossini M; Ghellere F; Caimmi C; Fassio A; Idolazzi L; Gatti D; Viapiana O
    Clin Rheumatol; 2018 Nov; 37(11):3093-3098. PubMed ID: 29995219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis.
    Rossini M; Viapiana O; Zanotti R; Tripi G; Perbellini O; Idolazzi L; Bonifacio M; Adami S; Gatti D
    Calcif Tissue Int; 2015 May; 96(5):410-6. PubMed ID: 25694360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
    Yamada S; Tsuruya K; Yoshida H; Taniguchi M; Haruyama N; Tanaka S; Eriguchi M; Nakano T; Kitazono T
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):844-51. PubMed ID: 23078546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
    Chaki O; Yoshikata I; Kikuchi R; Nakayama M; Uchiyama Y; Hirahara F; Gorai I
    J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
    Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ
    Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab.
    Gatti D; Viapiana O; Fracassi E; Idolazzi L; Dartizio C; Povino MR; Adami S; Rossini M
    J Bone Miner Res; 2012 Nov; 27(11):2259-63. PubMed ID: 22692843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis.
    Adami G; Orsolini G; Adami S; Viapiana O; Idolazzi L; Gatti D; Rossini M
    Calcif Tissue Int; 2016 Oct; 99(4):360-4. PubMed ID: 27307275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of serum osteocalcin and telopeptide-C in postmenopausal osteoporotic females.
    Lateef M; Baig M; Azhar A
    Osteoporos Int; 2010 May; 21(5):751-5. PubMed ID: 19597912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerostin and DKK1 in primary hyperparathyroidism.
    Viapiana O; Fracassi E; Troplini S; Idolazzi L; Rossini M; Adami S; Gatti D
    Calcif Tissue Int; 2013 Apr; 92(4):324-9. PubMed ID: 23430197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study.
    Garnero P; Sornay-Rendu E; Claustrat B; Delmas PD
    J Bone Miner Res; 2000 Aug; 15(8):1526-36. PubMed ID: 10934651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis.
    Mederle OA; Balas M; Ioanoviciu SD; Gurban CV; Tudor A; Borza C
    Clin Interv Aging; 2018; 13():1383-1389. PubMed ID: 30122910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.
    Garnero P; Sornay-Rendu E; Munoz F; Borel O; Chapurlat RD
    Osteoporos Int; 2013 Feb; 24(2):489-94. PubMed ID: 22525978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover.
    Gorai I; Taguchi Y; Chaki O; Nakayama M; Minaguchi H
    Calcif Tissue Int; 1997 Apr; 60(4):317-22. PubMed ID: 9075625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women.
    Kharroubi A; Saba E; Smoom R; Bader K; Darwish H
    Arch Osteoporos; 2017 Dec; 12(1):13. PubMed ID: 28124221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study.
    Ardawi MS; Rouzi AA; Al-Sibiani SA; Al-Senani NS; Qari MH; Mousa SA
    J Bone Miner Res; 2012 Dec; 27(12):2592-602. PubMed ID: 22836717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Bone Mineral Density and Bone Turnover Markers in Breast Cancer Patients and Bone-Only Metastasis.
    Kundaktepe BP; Sozer V; Kundaktepe FO; Durmus S; Papila C; Uzun H; Simsek G; Gelisgen R
    Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577803
    [No Abstract]   [Full Text] [Related]  

  • 20. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
    Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J
    J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.